Exact Mass: 391.1929524000001

Exact Mass Matches: 391.1929524000001

Found 103 metabolites which its exact mass value is equals to given mass value 391.1929524000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Orysastrobin

Orysastrobin

C18H25N5O5 (391.18556)


D010575 - Pesticides > D005659 - Fungicides, Industrial > D000073739 - Strobilurins D016573 - Agrochemicals

   

Diethylcarbamazine Citrate

Diethylcarbamazine Citrate

C16H29N3O8 (391.1954554)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors

   

roquefortine D

roquefortine D

C22H25N5O2 (391.200815)


CONFIDENCE Penicillium bissettii

   

3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one

3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one

C22H25N5O2 (391.200815)


   
   

(6E)-6-[[2-(2-methylbut-3-en-2-yl)-6-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,3,5-trione

(6E)-6-[[2-(2-methylbut-3-en-2-yl)-6-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,3,5-trione

C23H25N3O3 (391.189582)


   
   
   
   

(7E,9aS,11S,13S,13aS)-4-formyl-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-formyllycoposerramine-T

(7E,9aS,11S,13S,13aS)-4-formyl-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-formyllycoposerramine-T

C21H29NO6 (391.19947740000003)


   
   

(2R,3S)-3-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?-ethyl-2?,3?-dihydroxybutyrate|microtropin A

(2R,3S)-3-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?-ethyl-2?,3?-dihydroxybutyrate|microtropin A

C17H29NO9 (391.1842224)


   
   

1,4,5-TRI-O-ACETYL-3,6-DI-O-METHYL-2-N-METHYLACETAMIDO-2-DEOXYHEXITOL (1-D)

1,4,5-TRI-O-ACETYL-3,6-DI-O-METHYL-2-N-METHYLACETAMIDO-2-DEOXYHEXITOL (1-D)

C17H29NO9 (391.1842224)


   
   
   
   

Rizatriptan benzoate

Rizatriptan Benzoate (Maxalt)

C22H25N5O2 (391.200815)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Rizatriptan benzoate (Maxalt) is a 5-HT1 agonist.

   
   

C22H25N5O2_3-(1H-Imidazol-4-ylmethyl)-10b-(2-methyl-3-buten-2-yl)-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

NCGC00180346-02_C22H25N5O2_3-(1H-Imidazol-4-ylmethyl)-10b-(2-methyl-3-buten-2-yl)-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C22H25N5O2 (391.200815)


   

Ala Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Ala Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O5S (391.18893040000006)


   

Ala Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]propanamido]hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Ala Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Ala Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O5S (391.18893040000006)


   

Ala Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Cys Ala Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]propanamido]hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Cys Ala Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Cys Lys Ala Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Gly Gly Lys Met

(2S)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C15H29N5O5S (391.18893040000006)


   

Gly Gly Met Lys

(2S)-6-amino-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Gly Lys Gly Met

(2S)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C15H29N5O5S (391.18893040000006)


   

Gly Lys Met Gly

2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-(methylsulfanyl)butanamido]acetic acid

C15H29N5O5S (391.18893040000006)


   

Gly Met Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]acetamido}hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Gly Met Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]hexanamido]acetic acid

C15H29N5O5S (391.18893040000006)


   

Lys Ala Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O5S (391.18893040000006)


   

Lys Ala Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Lys Cys Ala Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]propanoic acid

C15H29N5O5S (391.18893040000006)


   

Lys Gly Gly Met

(2S)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-4-(methylsulfanyl)butanoic acid

C15H29N5O5S (391.18893040000006)


   

Lys Gly Met Gly

2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-4-(methylsulfanyl)butanamido]acetic acid

C15H29N5O5S (391.18893040000006)


   

Lys Met Gly Gly

2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]acetamido}acetic acid

C15H29N5O5S (391.18893040000006)


   
   

Met Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}acetamido)hexanoic acid

C15H29N5O5S (391.18893040000006)


   

Met Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}hexanamido]acetic acid

C15H29N5O5S (391.18893040000006)


   

Met Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]acetamido}acetic acid

C15H29N5O5S (391.18893040000006)


   
   

icas#6.1

(2S,3R,5R,6R)-5-hydroxy-6-(((2R,5R)-5-hydroxyhexan-2-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl-1H-indole-3-carboxylate

C21H29NO6 (391.19947740000003)


   

icas#6.2

(2S,3R,5R,6R)-5-hydroxy-6-(((2S,5R)-5-hydroxyhexan-2-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl-1H-indole-3-carboxylate

C21H29NO6 (391.19947740000003)


   

1-(TERT-BUTYLDIMETHYLSILYL)-4-CHLORO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE

1-(TERT-BUTYLDIMETHYLSILYL)-4-CHLORO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE

C20H31BClNO2Si (391.1905526)


   

R-96544 hydrochloride

R-96544 hydrochloride

C22H30ClNO3 (391.19141)


   

Binodenoson

Binodenoson

C17H25N7O4 (391.196793)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1]. Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

   
   

[4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C19H30BNO5Si (391.19862)


   

1H-Indole-1-carboxylic acid, 2-borono-6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 2-borono-6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, 1-(1,1-dimethylethyl) ester (9CI)

C19H30BNO5Si (391.19862)


   

1H-Indole-1-carboxylic acid, 2-borono-5-[[[dimethyl(1-methylethyl)silyl]oxy]methyl]-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 2-borono-5-[[[dimethyl(1-methylethyl)silyl]oxy]methyl]-, 1-(1,1-dimethylethyl) ester (9CI)

C19H30BNO5Si (391.19862)


   

1H-Benzimidazole,2-[1-[[1-[(4-fluorophenyl)methyl]-1H-tetrazol-5-yl]methyl]-4-piperidinyl]-(9CI)

1H-Benzimidazole,2-[1-[[1-[(4-fluorophenyl)methyl]-1H-tetrazol-5-yl]methyl]-4-piperidinyl]-(9CI)

C21H22FN7 (391.1920624)


   

4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide

4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide

C20H29N3O3S (391.1929524000001)


   

2-Borono-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester

2-Borono-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester

C19H30BNO5Si (391.19862)


   
   
   

3-Cyclohexyl-D-Alanyl-N-(3-Chlorobenzyl)-L-Prolinamide

3-Cyclohexyl-D-Alanyl-N-(3-Chlorobenzyl)-L-Prolinamide

C21H30ClN3O2 (391.202643)


   

D-Glucitol, 2-(acetylmethylamino)-2-deoxy-3,6-di-O-methyl-, 1,4,5-triacetate

D-Glucitol, 2-(acetylmethylamino)-2-deoxy-3,6-di-O-methyl-, 1,4,5-triacetate

C17H29NO9 (391.1842224)


   
   

Talathermophilins A

Talathermophilins A

C23H25N3O3 (391.189582)


A natural product found in Talaromyces thermophilus and Talaromyces thermophilus.

   

2-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-quinolinecarboxamide

2-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-quinolinecarboxamide

C23H25N3O3 (391.189582)


   

1-Ethyl-2-methyl-N-[(E)-(4-morpholin-4-ylphenyl)methylideneamino]benzimidazole-5-carboxamide

1-Ethyl-2-methyl-N-[(E)-(4-morpholin-4-ylphenyl)methylideneamino]benzimidazole-5-carboxamide

C22H25N5O2 (391.200815)


   
   
   

N-[[(2S,3R,4R)-1-acetyl-3-[4-(3-cyanophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide

N-[[(2S,3R,4R)-1-acetyl-3-[4-(3-cyanophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide

C23H25N3O3 (391.189582)


   

cyclobutyl-[(2S,3S)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclobutyl-[(2S,3S)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C23H25N3O3 (391.189582)


   

cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C23H25N3O3 (391.189582)


   

2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H25N3O3 (391.189582)


   

N-[[(2R,3S,4S)-1-acetyl-3-[4-(3-cyanophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide

N-[[(2R,3S,4S)-1-acetyl-3-[4-(3-cyanophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide

C23H25N3O3 (391.189582)


   

[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

C21H24F3N3O (391.187137)


   

[(2S,3R)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

[(2S,3R)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

C21H24F3N3O (391.187137)


   

cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C23H25N3O3 (391.189582)


   

cyclobutyl-[(2R,3S)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclobutyl-[(2R,3S)-2-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C23H25N3O3 (391.189582)


   

2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H25N3O3 (391.189582)


   

2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H25N3O3 (391.189582)


   

2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-6-[oxo(pyridin-4-yl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H25N3O3 (391.189582)


   
   

[2-[Acetyl(methyl)amino]-4,5-diacetyloxy-1-deuterio-3,6-dimethoxyhexyl] acetate

[2-[Acetyl(methyl)amino]-4,5-diacetyloxy-1-deuterio-3,6-dimethoxyhexyl] acetate

C17H29NO9 (391.1842224)


   
   

BI 99179

BI 99179

C23H25N3O3 (391.189582)


BI 99179 is a potent and selective type I fatty acid synthase (FAS) inhibitor with an IC50 of 79 nM. BI 99179 is a tool compound suitable for the in vivo validation of FAS as a target for lipid metabolism related diseases. BI 99179 exhibits significant exposure (both peripheral and central) upon oral administration in rats[1][2].

   

RAS inhibitor Abd-7

RAS inhibitor Abd-7

C23H25N3O3 (391.189582)


RAS inhibitor Abd-7, a potent RAS-binding compound (Kd=51 nM), is a RAS-effector protein-protein interaction (PPI) inhibitor. RAS inhibitor Abd-7 interacts with RAS inside the cells, prevents RAS-effector interactions and inhibits endogenous RAS-dependent signaling. RAS inhibitor Abd-7 impairs the PPI of various mutant KRAS proteins with PI3K, CRAF and RALGDS as well as NRAS Q61H and HRAS G12V[1].

   

(3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

(3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

C21H29NO6 (391.19947740000003)


   

3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C18H25N5O5 (391.18556)